Journal issues > Issue SPECIAL, January 2021 > Liquid biopsies for Hodgkin and DLBCL (differential) diagnosis

Liquid biopsies for Hodgkin and DLBCL (differential) diagnosis

Cell-free plasma DNA (cfDNA) and circulating tumour DNA (ctDNA) represent potential alternative sources of diagnostic information. During his lecture at the 2021 BHS general annual meeting Dr. Jo Van Dorpe discussed the potential of these liquid biopsies in the diagnostic work-up of different lymohoma subtypes.

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top